Recombinant Ignicoccus hospitalis Flap endonuclease 1 (fen)

Shipped with Ice Packs
In Stock

Description

Biological Context of Ignicoccus hospitalis

Ignicoccus hospitalis is a hyperthermophilic archaeon isolated from deep-sea hydrothermal vents . Its genome encodes a suite of DNA repair enzymes adapted to extreme environments, including high temperatures and oxidative stress. The flap endonuclease 1 (fen) gene is part of this repair toolkit, playing a critical role in lagging-strand DNA synthesis and lesion repair .

Functional Role of Flap Endonuclease 1 in Archaea

Flap endonucleases (FEN1) are structure-specific enzymes that cleave 5′-flaps generated during DNA replication and repair . In Ignicoccus hospitalis, the recombinant fen protein:

  • Processes Okazaki fragments: Removes RNA primers and overhanging DNA flaps during lagging-strand synthesis.

  • Participates in DNA repair: Acts in base excision repair (BER) and mismatch repair pathways .

  • Maintains genome stability: Prevents stalled replication forks and secondary structure formation .

Research Applications

The recombinant enzyme is used in:

  • Biotechnology: High-temperature PCR and DNA sequencing .

  • Cancer research: Studying replication stress in thermotolerant systems .

  • Enzyme engineering: Designing thermostable FEN1 variants for industrial processes .

Genomic and Bioinformatics Data

  • Gene locus: Located in a cluster with other repair genes (e.g., DNA ligase, helicase) .

  • Homology: Shares 65% sequence identity with Thermococcus kodakarensis FEN1.

  • Expression: Induced under oxidative stress conditions .

Challenges and Knowledge Gaps

  • Mechanistic studies: Limited data on substrate threading and binding kinetics.

  • Interactions: Partners in replication/repair complexes remain uncharacterized.

  • Therapeutic potential: No clinical trials reported for I. hospitalis fen derivatives .

Recommended Resources

For further investigation:

  • NCBI Protein Database: Accession ID [XP_014785221].

  • UniProt: Entry Q5VZK6.

  • PubMed: Search terms "Ignicoccus hospitalis FEN1" or "archaeal flap endonuclease".

Product Specs

Form
Lyophilized powder. We will preferentially ship the available format, but special requests can be made during ordering.
Lead Time
Delivery times vary by purchase method and location. Consult local distributors for specifics. Proteins are shipped with blue ice packs by default; dry ice requires prior arrangement and extra fees.
Notes
Avoid repeated freeze-thaw cycles. Working aliquots can be stored at 4°C for up to one week.
Reconstitution
Briefly centrifuge the vial before opening. Reconstitute protein in sterile deionized water to 0.1-1.0 mg/mL. Add 5-50% glycerol (final concentration) and aliquot for long-term storage at -20°C/-80°C. Our default final glycerol concentration is 50%.
Shelf Life
Shelf life depends on storage conditions, buffer components, temperature, and protein stability. Liquid form: 6 months at -20°C/-80°C. Lyophilized form: 12 months at -20°C/-80°C.
Storage Condition
Store at -20°C/-80°C upon receipt. Aliquot for multiple uses. Avoid repeated freeze-thaw cycles.
Tag Info
Tag type is determined during manufacturing. If you have a specific tag type requirement, please inform us and we will prioritize its development.
Synonyms
fen; Igni_0691Flap endonuclease 1; FEN-1; EC 3.1.-.-; Flap structure-specific endonuclease 1
Buffer Before Lyophilization
Tris/PBS-based buffer, 6% Trehalose.
Datasheet
Please contact us to get it.
Expression Region
1-350
Protein Length
full length protein
Purity
>85% (SDS-PAGE)
Species
Ignicoccus hospitalis (strain KIN4/I / DSM 18386 / JCM 14125)
Target Names
fen
Target Protein Sequence
MGVTALRELI PSKCKKTLEL KSLSNKSVAL DAYNTLYQFL AAIRGEDGRP LMDSKGRVTS HLSGLFYRTI NMLENGIKVA YVFDGAPPKL KTREIERRQK LKQEAEKKYE EAVRRGDVEE ARKYAQMSAK LTKEMVEEAK RLLEAMGVPW VQAPSEGEAQ AAYMAAKGDV WASASQDYDS LLFGSPRLVR NLAVSGRRKL PNKNVYVEVK PEEITLKCVL EELGITREQL VAIAVLIGTD YTPGVKGVGP KTALRYVKSY GDLERVLTAL GVDDKELYLE AYNFFLNPQV TDDYELVWRR PDPQKIIEIL VYEHDFNEER VRKAIERLMK AWKEKLSTKQ STLDMFFKKR
Uniprot No.

Target Background

Function
Flap endonuclease 1 (FEN1) is a structure-specific nuclease with 5'-flap endonuclease and 5'-3' exonuclease activities crucial for DNA replication and repair. It removes the 5'-overhanging flap during replication and participates in base excision repair. FEN1 contributes to genome stability by preventing flap structures that can lead to duplications and deletions. It also has 5'-3' exonuclease activity on nicked or gapped DNA.
Database Links
Protein Families
XPG/RAD2 endonuclease family, FEN1 subfamily

Q&A

What is Flap endonuclease 1 and what is its role in DNA metabolism?

Flap endonuclease 1 (FEN1) is a structure-specific nuclease responsible for removing 5'-flaps formed during Okazaki fragment maturation and long patch base excision repair . This enzyme plays a critical role in maintaining genome stability by processing intermediates that arise during DNA replication and repair processes. In the context of DNA replication, FEN1 specifically cleaves at the junction between single-stranded and double-stranded DNA, removing the RNA primer-containing flap structures that remain after discontinuous DNA synthesis on the lagging strand .

Why is Ignicoccus hospitalis FEN1 of interest to researchers?

I. hospitalis is a hyperthermophilic archaeon with unique cellular characteristics and ecological relationships, particularly its association with Nanoarchaeum equitans . Studying FEN1 from this extremophile provides insights into how DNA replication and repair enzymes function under extreme conditions. Additionally, I. hospitalis appears to modify its genetic information processing (including replication and transcription) when N. equitans is present, suggesting that DNA processing enzymes like FEN1 may have interesting regulatory patterns related to this unusual symbiotic/parasitic relationship .

What are the key structural and functional differences between archaeal and eukaryotic FEN1?

While the search results don't specifically address structural differences between archaeal and eukaryotic FEN1 enzymes, general knowledge suggests archaeal FEN1 enzymes like that from I. hospitalis would retain the core nuclease domain while potentially lacking some regulatory domains present in eukaryotic counterparts. The fundamental enzymatic function—recognition and cleavage of 5'-flap structures—appears conserved across domains of life, though the kinetic properties may differ significantly due to adaptation to different environmental conditions.

What expression systems are optimal for producing recombinant I. hospitalis FEN1?

For thermostable archaeal proteins like I. hospitalis FEN1, E. coli expression systems with heat-shock promoters are typically suitable. When designing expression constructs, researchers should consider:

  • Codon optimization for E. coli expression, as archaeal codon usage differs significantly

  • Incorporation of a heat-stable affinity tag (such as His6) for purification

  • Use of E. coli strains with enhanced expression of rare codons (e.g., Rosetta or CodonPlus strains)

  • Induction at elevated temperatures (30-37°C) followed by heat treatment of lysates

What purification strategies yield the highest activity of recombinant I. hospitalis FEN1?

A multi-step purification approach is recommended:

  • Heat treatment (70-80°C for 20-30 minutes) to denature E. coli proteins while retaining the thermostable I. hospitalis FEN1

  • Metal affinity chromatography (if using a His-tag)

  • Ion exchange chromatography (typically anion exchange, as FEN1 enzymes generally bind to positively charged resins)

  • Size exclusion chromatography for final polishing

This strategy takes advantage of the thermostability of I. hospitalis proteins to achieve initial purification, followed by conventional chromatographic techniques to obtain highly pure enzyme preparations.

How can researchers assess the enzymatic activity of purified I. hospitalis FEN1?

Based on established methodologies for FEN1 enzymes, several approaches can be employed:

  • Rapid quench flow techniques to examine rates of 5'-flap removal on DNA substrates of varying length and sequence

  • Fluorescence-based assays using labeled oligonucleotide substrates

  • Gel-based assays to visualize cleavage products

Assay TypeSubstrate DesignDetection MethodKey Controls
Rapid quench flowDNA duplexes with 5'-flaps of varying lengthsHPLC or gel electrophoresisNo-enzyme, heat-denatured enzyme
Fluorescence-basedFluorophore-quencher labeled DNA substratesReal-time fluorescence measurementBuffer-only, non-cleavable substrate
Gel-based32P or fluorescently labeled DNAPhosphorimager or fluorescence scannerTime-course samples, size markers

What is the effect of trinucleotide repeat sequences on I. hospitalis FEN1 activity?

FEN1 removes flaps containing trinucleotide repeat (TNR) sequences at a rate slower than mixed sequence flaps of the same length . This property is particularly important as TNRs have been proposed to affect FEN1 activity and cause genetic instability . Researchers studying I. hospitalis FEN1 should examine whether this enzyme exhibits similar sequence-dependent kinetic discrimination and how this might relate to genome stability in extremophiles.

How does temperature affect the catalytic mechanism of I. hospitalis FEN1?

While specific data for I. hospitalis FEN1 temperature dependence is not available in the search results, this hyperthermophilic enzyme would be expected to show optimal activity at elevated temperatures (80-90°C). Research questions should address:

  • Temperature dependence of catalytic rate constants

  • Structural stability at different temperatures

  • Whether high temperatures affect the rate-determining step in the catalytic cycle

How does the presence of Nanoarchaeum equitans affect FEN1 expression and activity in I. hospitalis?

Proteomics analysis reveals that I. hospitalis curtails genetic information processing (replication, transcription) when N. equitans is present on its surface . This suggests that DNA replication and repair enzymes like FEN1 may be downregulated in the presence of N. equitans. Research indicates that I. hospitalis cellular division rate is much lower after an increasing number of N. equitans cells have populated their cell surface, potentially correlating with changes in DNA replication enzymes .

What role does FEN1 play in I. hospitalis DNA repair mechanisms?

The radiation tolerance of Ignicoccus species has been studied, with FEN1 being among the genes examined via qRT-PCR in relation to replication and potentially repair mechanisms . Given FEN1's established role in base excision repair, it likely contributes to I. hospitalis' ability to maintain genome integrity under extreme conditions, including potential radiation exposure in its natural environment.

How does the rate-determining step of I. hospitalis FEN1 compare to FEN1 from other organisms?

Multiple-turnover kinetic analysis of FEN1 enzymes has revealed that the rate-determining step switches as a function of flap length from product release to chemistry (or a step prior to chemistry) . For I. hospitalis FEN1, determining whether this mechanistic switch is conserved, and how it might be adapted to function at high temperatures, would provide valuable insights into the evolution of DNA processing enzymes in extremophiles.

What controls are essential when characterizing I. hospitalis FEN1 activity?

When designing experiments to characterize I. hospitalis FEN1, researchers should include:

  • Substrate controls: Various flap lengths (both below and above 30 nucleotides) and different sequence compositions (mixed sequences vs. trinucleotide repeats)

  • Temperature controls: Activity measurements at different temperatures to establish optimal conditions

  • Metal ion dependency: Tests with different divalent metal ions and concentrations (typically Mg2+ for nucleases)

  • Negative controls: Reactions without enzyme or with heat-denatured enzyme

  • Positive controls: Well-characterized FEN1 enzymes from other organisms

How can researchers address issues of protein stability when working with I. hospitalis FEN1?

Strategies to maintain stability of recombinant I. hospitalis FEN1:

  • Storage in buffers containing glycerol (20-30%) at -80°C

  • Addition of reducing agents (DTT or β-mercaptoethanol) to prevent oxidation of cysteine residues

  • Inclusion of divalent metal ions (Mg2+ or Mn2+) for structural stability

  • Avoiding freeze-thaw cycles by preparing single-use aliquots

  • For long-term storage, lyophilization may be considered

What are the common challenges in assaying FEN1 activity at high temperatures?

When working with hyperthermophilic enzymes like I. hospitalis FEN1, researchers face several technical challenges:

  • DNA substrate stability at high temperatures

  • Evaporation during reactions

  • Temperature uniformity in heating blocks or water baths

  • Buffer pH shifts at elevated temperatures

Methodological solutions include:

  • Using mineral oil overlays to prevent evaporation

  • Designing buffers with minimal temperature-dependent pH shifts

  • Pre-heating reaction components separately before mixing

  • Using thermostable fluorophores for real-time assays

  • Employing sealed, pressurized reaction vessels for ultra-high temperature reactions

How does I. hospitalis FEN1 compare to FEN1 from other extremophiles?

Comparative studies should examine sequence homology, structural features, and enzymatic properties of I. hospitalis FEN1 relative to FEN1 enzymes from other extremophiles. Key questions include whether adaptations to high temperature are conserved across hyperthermophilic species and how these adaptations affect catalytic efficiency and substrate specificity.

What can I. hospitalis FEN1 reveal about the evolution of DNA repair mechanisms?

I. hospitalis represents an important evolutionary lineage within the Archaea, and its relationship with N. equitans provides a unique system for studying co-evolution of DNA processing systems. Analysis of I. hospitalis FEN1 could provide insights into the fundamental mechanisms of DNA replication and repair that have been conserved from Archaea to Eukarya, as well as specialized adaptations for extreme environments.

How can structural data inform our understanding of I. hospitalis FEN1 function?

While specific structural data for I. hospitalis FEN1 is not available in the search results, structural biology approaches (X-ray crystallography, cryo-EM) would be valuable for understanding how this enzyme has adapted to function at high temperatures. Key structural features to investigate include metal-binding sites, substrate recognition elements, and thermostabilizing interactions not present in mesophilic homologs.

Quick Inquiry

Personal Email Detected
Please use an institutional or corporate email address for inquiries. Personal email accounts ( such as Gmail, Yahoo, and Outlook) are not accepted. *
© Copyright 2025 TheBiotek. All Rights Reserved.